121 related articles for article (PubMed ID: 16702788)
1. Immunological and immunogenetic markers in sporadic Alzheimer's disease.
Lio D; Scola L; Romano GC; Candore G; Caruso C
Aging Clin Exp Res; 2006 Apr; 18(2):163-6. PubMed ID: 16702788
[TBL] [Abstract][Full Text] [Related]
2. A polymorphism in the complement component C1r is not associated with sporadic Alzheimer's disease.
Rosenmann H; Meiner Z; Kahana E; Aladjem Z; Friedman G; Ben-Yehuda A; Grenader T; Wertman E; Abramsky O
Neurosci Lett; 2003 Jan; 336(2):101-4. PubMed ID: 12499050
[TBL] [Abstract][Full Text] [Related]
3. Genetic predisposition to inflammation: a new risk factor of Alzheimer's disease.
Wan Y; Wang G; Chen SD
Neurosci Bull; 2008 Oct; 24(5):314-22. PubMed ID: 18839025
[TBL] [Abstract][Full Text] [Related]
4. Gene expression changes by amyloid beta peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes.
Walker DG; Link J; Lue LF; Dalsing-Hernandez JE; Boyes BE
J Leukoc Biol; 2006 Mar; 79(3):596-610. PubMed ID: 16365156
[TBL] [Abstract][Full Text] [Related]
5. The early involvement of the innate immunity in the pathogenesis of late-onset Alzheimer's disease: neuropathological, epidemiological and genetic evidence.
Eikelenboom P; Veerhuis R; van Exel E; Hoozemans JJ; Rozemuller AJ; van Gool WA
Curr Alzheimer Res; 2011 Mar; 8(2):142-50. PubMed ID: 21345167
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory Cytokines and Alzheimer's Disease: A Review from the Perspective of Genetic Polymorphisms.
Su F; Bai F; Zhang Z
Neurosci Bull; 2016 Oct; 32(5):469-80. PubMed ID: 27568024
[TBL] [Abstract][Full Text] [Related]
7. Biological and genetic markers of sporadic Alzheimer's disease.
Engelborghs S; De Deyn PP
Acta Med Okayama; 2001 Apr; 55(2):55-63. PubMed ID: 11332200
[TBL] [Abstract][Full Text] [Related]
8. Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer's Disease Pathogenesis.
Meyer PF; Savard M; Poirier J; Labonté A; Rosa-Neto P; Weitz TM; Town T; Breitner J; ;
J Alzheimers Dis; 2018; 63(2):577-590. PubMed ID: 29660934
[TBL] [Abstract][Full Text] [Related]
9. Effect of proinflammatory gene polymorphisms on the risk of Alzheimer's disease.
Flex A; Giovannini S; Biscetti F; Liperoti R; Spalletta G; Straface G; Landi F; Angelini F; Caltagirone C; Ghirlanda G; Bernabei R
Neurodegener Dis; 2014; 13(4):230-6. PubMed ID: 24022074
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly.
Sardi F; Fassina L; Venturini L; Inguscio M; Guerriero F; Rolfo E; Ricevuti G
Autoimmun Rev; 2011 Dec; 11(2):149-53. PubMed ID: 21996556
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E genotype in patients with Alzheimer's disease.
Luo B; Chen Z; Zhang Y; Pan X; Li X; Chen F
Chin Med J (Engl); 2003 Aug; 116(8):1220-2. PubMed ID: 12935416
[TBL] [Abstract][Full Text] [Related]
12. [The immune system and Alzheimer's disease].
van Exel E; Eikelenboom P; Comijs HC; Kurniawan C; Frölich M; Smit JH; Stek ML; Scheltens P; Eefsting JE; Westendorp RG
Tijdschr Psychiatr; 2011; 53(9):637-43. PubMed ID: 21898320
[TBL] [Abstract][Full Text] [Related]
13. Genetic markers for diagnosis and pathogenesis of Alzheimer's disease.
Kim DH; Yeo SH; Park JM; Choi JY; Lee TH; Park SY; Ock MS; Eo J; Kim HS; Cha HJ
Gene; 2014 Jul; 545(2):185-93. PubMed ID: 24838203
[TBL] [Abstract][Full Text] [Related]
14. An IL-1 alpha susceptibility polymorphism in Alzheimer's disease:new fuel for the inflammation hypothesis.
Rogers J
Neurology; 2000 Aug; 55(4):464-5. PubMed ID: 10953173
[No Abstract] [Full Text] [Related]
15. Important differences between human and mouse APOE gene promoters: limitation of mouse APOE model in studying Alzheimer's disease.
Maloney B; Ge YW; Alley GM; Lahiri DK
J Neurochem; 2007 Nov; 103(3):1237-57. PubMed ID: 17854398
[TBL] [Abstract][Full Text] [Related]
16. [Alzheimer's disease and genes].
Jørgensen AL; Johannsen P
Ugeskr Laeger; 1997 Sep; 159(38):5648-52. PubMed ID: 9340870
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in inflammatory genes and the risk of Alzheimer disease.
McGeer PL; McGeer EG
Arch Neurol; 2001 Nov; 58(11):1790-2. PubMed ID: 11708985
[TBL] [Abstract][Full Text] [Related]
18. Lipids and the pathogenesis of Alzheimer's disease: is there a link?
Mielke MM; Lyketsos CG
Int Rev Psychiatry; 2006 Apr; 18(2):173-86. PubMed ID: 16777671
[TBL] [Abstract][Full Text] [Related]
19. Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease.
Mattsson N; Eriksson O; Lindberg O; Schöll M; Lampinen B; Nilsson M; Insel PS; Lautner R; Strandberg O; van Westen D; Zetterberg H; Blennow K; Palmqvist S; Stomrud E; Hansson O
Neurobiol Aging; 2018 Nov; 71():81-90. PubMed ID: 30107289
[TBL] [Abstract][Full Text] [Related]
20. Lack of association of interleukin-1beta polymorphism with Alzheimer's disease in the Jewish population.
Rosenmann H; Meiner Z; Dresner-Pollak R; Kahana E; Aladjem Z; Grenader T; Wertman E; Abramsky O
Neurosci Lett; 2004 Jun; 363(2):131-3. PubMed ID: 15172100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
